Novo Nordisk Inc. et al v. Meitheal Pharmaceuticals, Inc. et al
Plaintiff: Novo Nordisk Inc. and Novo Nordisk A/S
Defendant: Meitheal Pharmaceuticals, Inc. and Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Case Number: 1:2023cv01195
Filed: October 20, 2023
Court: US District Court for the District of Delaware
Presiding Judge: Colm F Connolly
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on December 18, 2023. A more recent docket listing may be available from PACER.

Date Filed Document Text
December 18, 2023 Opinion or Order SO ORDERED, re #11 Unopposed MOTION for Extension of Time to File Answer , move, or otherwise respond to the Complaint in this action to December 22, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Answer Deadlines: Meitheal Pharmaceuticals, Inc. answer due 12/22/2023; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. answer due 12/22/2023. Ordered by Judge Colm F. Connolly on 12/18/2023. (kmd)
December 15, 2023 Filing 11 Unopposed MOTION for Extension of Time to File Answer , move, or otherwise respond to the Complaint in this action to December 22, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
November 14, 2023 Filing 10 Unopposed MOTION for Extension of Time to Respond to Complaint (D.I. 1) - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis)
November 14, 2023 Opinion or Order SO ORDERED, re #10 Unopposed MOTION for Extension of Time to Respond to Complaint (D.I. 1), filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Answer Deadlines: Meitheal Pharmaceuticals, Inc. answer due 12/15/2023; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. answer due 12/15/2023. Ordered by Judge Colm F. Connolly on 11/14/2023. (kmd)
October 25, 2023 Filing 9 STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf)
October 25, 2023 Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms)
October 24, 2023 Filing 8 AFFIDAVIT of Service for Summons, Complaint and related papers served on Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. on October 23, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian)
October 23, 2023 Filing 7 SUMMONS Returned Executed by Novo Nordisk Inc., Novo Nordisk A/S.Meitheal Pharmaceuticals, Inc. served on 10/23/2023, answer due 11/13/2023. (Egan, Brian)
October 20, 2023 Filing 6 Summons Issued as to Meitheal Pharmaceuticals, Inc. on 10/20/2023; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. on 10/20/2023. (Attachments: #1 Summons Issued) (vfm)
October 20, 2023 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk A/S, Corporate Parent Novo Nordisk US Holdings Inc., Corporate Parent Novo Nordisk Commercial Holdings, Inc. for Novo Nordisk Inc.; Corporate Parent Novo Nordisk Foundation, Corporate Parent Novo Holdings A/S for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (vfm)
October 20, 2023 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,114,833 B2 ;9,265,893 B2. (vfm)
October 20, 2023 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/08/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/8/2026. (vfm)
October 20, 2023 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm)
October 20, 2023 Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Meitheal Pharmaceuticals, Inc., Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. ( Filing fee $ 402, receipt number ADEDC-4254543.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet) (vfm)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Novo Nordisk Inc. et al v. Meitheal Pharmaceuticals, Inc. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novo Nordisk Inc.
Represented By: Jack B. Blumenfeld
Represented By: Brian P. Egan
Represented By: Travis J Murray
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novo Nordisk A/S
Represented By: Jack B. Blumenfeld
Represented By: Brian P. Egan
Represented By: Travis J Murray
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Meitheal Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?